Pharmacovigilance in personalized medicine: Adapting to a new era of drug development

[Image courtesy of LeoWolfert via iStock]

One of the ways that the COVID-19 pandemic had a profound impact on the pharma industry was how it highlighted the importance of pharmacovigilance. As personalized medicine gained traction, drug developers had to evolve their strategies to ensure safety and efficacy. In their report, “The Future of Pharmacovigilance,” Dr. Sabine Jeck-Thole and Ben Enejo, partners at Arthur D. Little, discussed the challenges and opportunities in this new landscape.

Embracing the shift in perception of adverse events and side effects

“When we heard about adverse events and side effects, it was not bad news,” Jeck-Thole said in an interview. “It indicated that we understood our drug or vaccine much better than without any safety information.” She emphasized that this shift in perception was essential for the industry as it moved towards pharmacovigilance in personal…

Read more
  • 0